Published in EMBO J on July 01, 1989
Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med (1993) 5.49
Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site. Proc Natl Acad Sci U S A (1991) 3.71
PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity. Mol Cell Biol (1992) 3.32
Separate elements control DJ and VDJ rearrangement in a transgenic recombination substrate. EMBO J (1990) 2.52
Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res (1995) 2.33
PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer. Mol Cell Biol (1993) 2.08
Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases. Mol Cell Biol (2005) 2.06
Interactome maps of mouse gene regulatory domains reveal basic principles of transcriptional regulation. Cell (2013) 2.06
Evolutionarily conserved Ets family members display distinct DNA binding specificities. J Exp Med (1992) 2.04
Elucidation of IgH intronic enhancer functions via germ-line deletion. Proc Natl Acad Sci U S A (2005) 1.85
Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes. EMBO J (1991) 1.83
AID and somatic hypermutation. Adv Immunol (2010) 1.74
Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors. Mol Cell Biol (1991) 1.74
Interaction between a novel F9-specific factor and octamer-binding proteins is required for cell-type-restricted activity of the fibroblast growth factor 4 enhancer. Mol Cell Biol (1994) 1.61
The importance of the 3'-enhancer region in immunoglobulin kappa gene expression. Nucleic Acids Res (1990) 1.56
Structure and expression of the human immunoglobulin lambda genes. J Exp Med (1990) 1.56
The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function. J Virol (1990) 1.55
Cells strongly expressing Ig(kappa) transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers. EMBO J (1997) 1.46
Deletion of the immunoglobulin kappa chain intron enhancer abolishes kappa chain gene rearrangement in cis but not lambda chain gene rearrangement in trans. EMBO J (1993) 1.44
Gene targeting in the Ig kappa locus: efficient generation of lambda chain-expressing B cells, independent of gene rearrangements in Ig kappa. EMBO J (1993) 1.38
Promoter, enhancer and silencer elements regulate rearrangement of an immunoglobulin transgene. EMBO J (1993) 1.34
Identification of a T-cell-specific transcriptional enhancer located 3' of C gamma 1 in the murine T-cell receptor gamma locus. Proc Natl Acad Sci U S A (1991) 1.30
Engineered secreted T-cell receptor alpha beta heterodimers. Proc Natl Acad Sci U S A (1991) 1.30
Important roles for E protein binding sites within the immunoglobulin kappa chain intronic enhancer in activating Vkappa Jkappa rearrangement. J Exp Med (2004) 1.27
E2A expression, nuclear localization, and in vivo formation of DNA- and non-DNA-binding species during B-cell development. Mol Cell Biol (1993) 1.26
An immunoglobulin mutator that targets G.C base pairs. Proc Natl Acad Sci U S A (1996) 1.26
Silencing of the expression of the immunoglobulin kappa gene in non-B cells. Mol Cell Biol (1991) 1.24
The immunoglobulin heavy chain locus contains another B-cell-specific 3' enhancer close to the alpha constant region. Mol Cell Biol (1993) 1.21
Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression. Mol Cell Biol (1990) 1.19
Transcription factor Pip can enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains. Mol Cell Biol (1998) 1.19
C/EBP-like proteins binding to the functional box-alpha and box-beta of the second enhancer of hepatitis B virus. Mol Cell Biol (1991) 1.17
BSAP can repress enhancer activity by targeting PU.1 function. Mol Cell Biol (2000) 1.12
Conformational alteration of Oct-1 upon DNA binding dictates selectivity in differential interactions with related transcriptional coactivators. Mol Cell Biol (1996) 1.12
PU.1 can participate in an active enhancer complex without its transcriptional activation domain. Proc Natl Acad Sci U S A (1997) 1.10
Regulation and a possible stage-specific function of Oct-2 during pre-B-cell differentiation. Mol Cell Biol (1991) 1.07
Deletions of immunoglobulin C kappa region characterized by the circular excision products in mouse splenocytes. J Exp Med (1991) 1.02
Kappa immunoglobulin promoters and enhancers display developmentally controlled interactions. Nucleic Acids Res (1993) 1.01
A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3' enhancer. Mol Cell Biol (1996) 1.01
Critical roles of the immunoglobulin intronic enhancers in maintaining the sequential rearrangement of IgH and Igk loci. J Exp Med (2006) 1.01
Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material. Clin Exp Immunol (1992) 1.00
Activation of the immunoglobulin kappa 3' enhancer in pre-B cells correlates with the suppression of a nuclear factor binding to a sequence flanking the active core. Nucleic Acids Res (1994) 1.00
The Downstream Transcriptional Enhancer, Ed, positively regulates mouse Ig kappa gene expression and somatic hypermutation. J Immunol (2008) 0.98
Characterization of the human immunoglobulin kappa gene 3' enhancer: functional importance of three motifs that demonstrate B-cell-specific in vivo footprints. Mol Cell Biol (1992) 0.96
Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors. Mol Cell Biol (1992) 0.93
Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells. EMBO J (1993) 0.93
Comparison of somatic mutation frequency among immunoglobulin genes. J Exp Med (1994) 0.92
Coordinate transcription and V(D)J recombination of the kappa immunoglobulin light-chain locus: NF-kappaB-dependent and -independent pathways of activation. Mol Cell Biol (1997) 0.91
Identification of USF as the ubiquitous murine factor that binds to and stimulates transcription from the immunoglobulin lambda 2-chain promoter. Nucleic Acids Res (1992) 0.89
Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms. Nucleic Acids Res (1994) 0.89
Analysis of a T cell receptor gene as a target of the somatic hypermutation mechanism. J Exp Med (1992) 0.88
Immunoglobulin heavy-chain enhancer is required to maintain transfected gamma 2A gene expression in a pre-B-cell line. Mol Cell Biol (1990) 0.88
Divergent roles of RelA and c-Rel in establishing chromosomal loops upon activation of the Igkappa gene. J Immunol (2009) 0.86
The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription. J Immunol (2010) 0.86
Vκ gene repertoire and locus contraction are specified by critical DNase I hypersensitive sites within the Vκ-Jκ intervening region. J Immunol (2013) 0.85
The promoter of the endo A cytokeratin gene is activated by a 3' downstream enhancer. Nucleic Acids Res (1991) 0.84
Mutation in a reporter gene depends on proximity to and transcription of immunoglobulin variable transgenes. Proc Natl Acad Sci U S A (1991) 0.83
Classical Mus musculus Igκ enhancers support transcription but not high level somatic hypermutation from a V-lambda promoter in chicken DT40 cells. PLoS One (2011) 0.81
EBV-encoded LMP1 upregulates Igκ 3'enhancer activity and Igκ expression in nasopharyngeal cancer cells by activating the Ets-1 through ERKs signaling. PLoS One (2012) 0.81
A major deletion in the Vκ-Jκ intervening region results in hyperelevated transcription of proximal Vκ genes and a severely restricted repertoire. J Immunol (2014) 0.80
Identification of tissue specific nuclear proteins: DNA sequence and protein binding regions in the T cell receptor beta J-C intron. Nucleic Acids Res (1990) 0.80
A novel pax5-binding regulatory element in the igκ locus. Front Immunol (2014) 0.79
A new hypersensitive site, HS10, and the enhancers, E3' and Ed, differentially regulate Igκ gene expression. J Immunol (2012) 0.79
A novel transgenic chimaeric mouse system for the rapid functional evaluation of genes encoding secreted proteins. Nucleic Acids Res (2005) 0.78
Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU. Nucleic Acids Res (2000) 0.77
Loss of an Igκ gene enhancer in mature B cells results in rapid gene silencing and partial reversible dedifferentiation. Mol Cell Biol (2013) 0.77
Isolation and characterization of the genomic human CD7 gene: structural similarity with the murine Thy-1 gene. Proc Natl Acad Sci U S A (1991) 0.77
Multiple factors influence the contribution of individual immunoglobulin light chain genes to the naïve antibody repertoire. BMC Immunol (2014) 0.76
The plasmacytoma J558L lacks constitutively active NF-kappa B and is deficient in early response gene activation. Nucleic Acids Res (1991) 0.75
Regulation of kappa immunoglobulin gene transcription in vitro. Nucleic Acids Res (1990) 0.75
The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications. West J Med (1992) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res (1984) 86.56
A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell (1983) 20.32
Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell (1986) 20.08
A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell (1983) 18.86
Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell (1987) 15.79
Immunoglobulin gene transcription is activated by downstream sequence elements. Cell (1983) 15.53
Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell (1986) 15.30
Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences. Cell (1985) 10.00
Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells. EMBO J (1983) 10.00
B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science (1985) 9.73
Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements. Cell (1985) 8.16
Structure of the 5' ends of immunoglobulin genes: a novel conserved sequence. Proc Natl Acad Sci U S A (1984) 7.74
Correct transcription of an immunoglobulin kappa gene requires an upstream fragment containing conserved sequence elements. Nature (1984) 7.66
A lymphocyte-specific enhancer in the mouse immunoglobulin kappa gene. Nature (1984) 6.05
Variability in the lambda light chain sequences of mouse antibody. Nature (1970) 5.71
Mouse myeloma proteins with antihapten antibody acitivity. The protein produced by plasma cell tumor MOPC-315. Biochemistry (1968) 4.83
Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence. Cell (1985) 4.38
Interferon response element of the human gene 6-16. EMBO J (1988) 4.11
The role of the kappa enhancer and its binding factor NF-kappa B in the developmental regulation of kappa gene transcription. Cell (1987) 3.72
Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene. EMBO J (1985) 3.68
A single DNA response element can confer inducibility by both alpha- and gamma-interferons. Proc Natl Acad Sci U S A (1989) 3.33
Fine mapping of an immunoglobulin gene activator. Mol Cell Biol (1984) 3.06
Transcription of T cell receptor beta-chain genes is controlled by a downstream regulatory element. EMBO J (1988) 2.93
Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts. Proc Natl Acad Sci U S A (1986) 2.66
A novel, inducible and T cell-specific enhancer located at the 3' end of the T cell receptor alpha locus. EMBO J (1989) 2.64
Translocation of the myc cellular oncogene to the immunoglobulin heavy chain locus in murine plasmacytomas is an imprecise reciprocal exchange. Cell (1984) 2.60
Expression of immunoglobulin heavy chain at a high level in the absence of a proposed immunoglobulin enhancer element in cis. Proc Natl Acad Sci U S A (1984) 2.55
Complete DNA sequence of lymphotropic papovavirus: prototype of a new species of the polyomavirus genus. Virology (1985) 2.53
Novel kappa light-chain gene rearrangements in mouse lambda light chain-producing B lymphocytes. Nature (1984) 2.42
Cell-type preference of immunoglobulin kappa and lambda gene promoters. EMBO J (1985) 2.22
A viral enhancer element specifically active in human haematopoietic cells. Nature (1985) 1.95
A transcriptional enhancer 3' of C beta 2 in the T cell receptor beta locus. Science (1988) 1.91
Deletion of the IgH enhancer does not reduce immunoglobulin heavy chain production of a hybridoma IgD class switch variant. EMBO J (1984) 1.78
Deletions of kappa chain constant region genes in mouse lambda chain-producing B cells involve intrachromosomal DNA recombinations similar to V-J joining. Proc Natl Acad Sci U S A (1985) 1.61
Induction of immunoglobulin isotype switching in cultured I.29 B lymphoma cells. Characterization of the accompanying rearrangements of heavy chain genes. J Exp Med (1985) 1.59
Cloning of immunoglobulin kappa light chain genes from mouse liver and myeloma MOPC 173. Nucleic Acids Res (1979) 1.54
Interferons as gene activators. Cloning of the 5' terminus and the control segment of an interferon activated gene. J Biol Chem (1986) 1.53
Independent immunoglobulin class-switch events occurring in a single myeloma cell line. Mol Cell Biol (1985) 1.51
DNA sequences near the site of reciprocal recombination between a c-myc oncogene and an immunoglobulin switch region. Proc Natl Acad Sci U S A (1983) 1.49
Complex protein binding within the mouse immunoglobulin heavy-chain enhancer. Mol Cell Biol (1987) 1.48
Deletion of a B-cell-specific enhancer affects transfected, but not endogenous, immunoglobulin heavy-chain gene expression. Proc Natl Acad Sci U S A (1985) 1.45
Promoter and enhancer elements in the rearranged alpha chain gene of the human T cell receptor. EMBO J (1987) 1.40
Beta transforming growth factors are potential regulators of B lymphopoiesis. J Exp Med (1987) 1.39
Reciprocal chromosome translocation between c-myc and immunoglobulin gamma 2b genes. Nature (1983) 1.31
Novel type of murine B-cell lymphoma. Nature (1978) 1.29
Induction of kappa transcription by interferon-gamma without activation of NF-kappa B. Science (1988) 1.24
Stable propagation of the active transcriptional state of an immunoglobulin mu gene requires continuous enhancer function. Cell (1988) 1.23
Evidence for transient requirement of the IgH enhancer. Nucleic Acids Res (1985) 1.10
Linking of the human immunoglobulin VK and JKCK regions by chromosomal walking. Nucleic Acids Res (1987) 1.09
Complementation between two cell lines lacking kappa enhancer activity: implications for the developmental control of immunoglobulin transcription. EMBO J (1988) 1.08
Characterization of immunoglobulin enhancer deletions in murine plasmacytomas. EMBO J (1985) 1.07
Transcription cell type specificity is conferred by an immunoglobulin VH gene promoter that includes a functional consensus sequence. Cell (1985) 4.38
Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature (1986) 4.19
Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med (1987) 3.82
B cells acquire antigen from target cells after synapse formation. Nature (2001) 3.31
Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. Immunity (1998) 3.27
Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity (1998) 3.16
Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature (2001) 3.09
Elements regulating somatic hypermutation of an immunoglobulin kappa gene: critical role for the intron enhancer/matrix attachment region. Cell (1994) 3.06
Hyperresponsive B cells in CD22-deficient mice. Science (1996) 2.86
TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity (1998) 2.76
A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature (1985) 2.63
Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J (1999) 2.58
Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice. Nucleic Acids Res (1997) 2.44
Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. Proc Natl Acad Sci U S A (1993) 2.30
Activation of mouse complement by monoclonal mouse antibodies. Eur J Immunol (1981) 2.11
Somatic hypermutation. Curr Opin Immunol (1995) 2.08
The B-cell antigen receptor of the five immunoglobulin classes. Nature (1991) 1.97
Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci U S A (1998) 1.94
Discriminating intrinsic and antigen-selected mutational hotspots in immunoglobulin V genes. Immunol Today (1993) 1.93
Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med (1999) 1.83
Somatic hypermutation of immunoglobulin kappa may depend on sequences 3' of C kappa and occurs on passenger transgenes. EMBO J (1991) 1.83
Regulation of membrane IgM expression in secretory B cells: translational and post-translational events. EMBO J (1987) 1.82
Targeting of non-Ig sequences in place of the V segment by somatic hypermutation. Nature (1995) 1.80
Both DNA strands of antibody genes are hypermutation targets. Proc Natl Acad Sci U S A (1998) 1.77
Recombinant antibodies possessing novel effector functions. Nature (1985) 1.76
Somatic hypermutation of immunoglobulin genes. Annu Rev Immunol (1996) 1.72
Codon bias targets mutation. Nature (1995) 1.69
Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination. Proc Natl Acad Sci U S A (2001) 1.69
A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus. Nature (1990) 1.65
The importance of the 3'-enhancer region in immunoglobulin kappa gene expression. Nucleic Acids Res (1990) 1.56
Disruption of mouse polymerase zeta (Rev3) leads to embryonic lethality and impairs blastocyst development in vitro. Curr Biol (2000) 1.54
The mouse IgH 3'-enhancer. Eur J Immunol (1991) 1.50
Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med (2000) 1.49
Switch from hapten-specific immunoglobulin M to immunoglobulin D secretion in a hybrid mouse cell line. Proc Natl Acad Sci U S A (1981) 1.48
Cells strongly expressing Ig(kappa) transgenes show clonal recruitment of hypermutation: a role for both MAR and the enhancers. EMBO J (1997) 1.46
Expression and targeting of intracellular antibodies in mammalian cells. EMBO J (1990) 1.38
Purification and properties of Klebsiella aerogenes D-arabitol dehydrogenase. Biochem J (1979) 1.38
Association of CD22 with the B cell antigen receptor. Eur J Immunol (1993) 1.35
Somatic hypermutation in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PK(cs)) or recombination-activating gene (RAG)1 activity. J Exp Med (2000) 1.34
B cells extract and present immobilized antigen: implications for affinity discrimination. EMBO J (2000) 1.31
The half-life of immunoglobulin mRNA increases during B-cell differentiation: a possible role for targeting to membrane-bound polysomes. Genes Dev (1988) 1.31
Reciprocal chromosome translocation between c-myc and immunoglobulin gamma 2b genes. Nature (1983) 1.31
Polymeric immunoglobulin M is secreted by transfectants of non-lymphoid cells in the absence of immunoglobulin J chain. EMBO J (1987) 1.30
The targeting of somatic hypermutation. Semin Immunol (1996) 1.29
The immunogenicity of chimeric antibodies. J Exp Med (1989) 1.25
The sequence of the mu transmembrane segment determines the tissue specificity of the transport of immunoglobulin M to the cell surface. J Exp Med (1990) 1.18
The alpha/beta sheath and its cytoplasmic tyrosines are required for signaling by the B-cell antigen receptor but not for capping or for serine/threonine-kinase recruitment. Proc Natl Acad Sci U S A (1994) 1.18
Somatic mutation of immunoglobulin lambda chains: a segment of the major intron hypermutates as much as the complementarity-determining regions. Proc Natl Acad Sci U S A (1994) 1.16
Somatic hypermutation of Ig genes in patients with xeroderma pigmentosum (XP-D). Int Immunol (1996) 1.14
Acceleration of intracellular targeting of antigen by the B-cell antigen receptor: importance depends on the nature of the antigen-antibody interaction. EMBO J (1997) 1.12
The c-MYC allele that is translocated into the IgH locus undergoes constitutive hypermutation in a Burkitt's lymphoma line. Oncogene (2000) 1.11
The immunoglobulin (Ig)alpha and Igbeta cytoplasmic domains are independently sufficient to signal B cell maturation and activation in transgenic mice. J Exp Med (1997) 1.10
A repertoire of monoclonal antibodies with human heavy chains from transgenic mice. Proc Natl Acad Sci U S A (1989) 1.08
Antigen presentation by the B cell antigen receptor is driven by the alpha/beta sheath and occurs independently of its cytoplasmic tyrosines. Cell (1993) 1.08
Dysregulated expression of the Cd22 gene as a result of a short interspersed nucleotide element insertion in Cd22a lupus-prone mice. J Immunol (2000) 1.06
Mice carrying a CD20 gene disruption. Immunogenetics (1998) 1.06
Multiple sequences from downstream of the J kappa cluster can combine to recruit somatic hypermutation to a heterologous, upstream mutation domain. Eur J Immunol (1998) 1.02
Chromosome translocation activates heterogeneously initiated, bipolar transcription of a mouse c-myc gene. EMBO J (1985) 1.02
Investigations into the Klebsiella aerogenes pentitol operons using specialised transducing phages lambdaprbt and lambdaprbt dal. J Mol Biol (1979) 0.98
The contribution of somatic hypermutation to the diversity of serum immunoglobulin: dramatic increase with age. Immunity (2000) 0.97
Production of antibody-tagged enzymes by myeloma cells: application to DNA polymerase I Klenow fragment. Gene (1986) 0.93
Purification and properties of D-ribulokinase and D-xylulokinase from Klebsiella aerogenes. Biochem J (1981) 0.93
Antibody repertoires of four- and five-feature translocus mice carrying human immunoglobulin heavy chain and kappa and lambda light chain yeast artificial chromosomes. J Immunol (1999) 0.92
Cellular selection leads to age-dependent and reversible down-regulation of transgenic immunoglobulin light chain genes. Int Immunol (1989) 0.90
Strategies for expressing human antibody repertoires in transgenic mice. Immunol Today (1996) 0.90
Membrane immunoglobulin without sheath or anchor. Mol Immunol (1993) 0.88
Sequence of a secondary phage lambda attachment site located between the pentitol operons of Klebsiella aerogenes. Biochem J (1981) 0.87
The diversity of antigen-specific monoclonal antibodies from transgenic mice bearing human immunoglobulin gene miniloci. Eur J Immunol (1994) 0.86
Epstein-Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells. J Virol (2001) 0.86
Maturation of the immune response. Adv Protein Chem (1996) 0.85
Antibodies generated from human immunoglobulin miniloci in transgenic mice. Nucleic Acids Res (1994) 0.84
Somatic hypermutation of immunoglobulin kappa transgenes: association of mutability with demethylation. Immunol Cell Biol (2001) 0.84
Antibody expression from the core region of the human IgH locus reconstructed in transgenic mice using bacteriophage P1 clones. Genomics (1996) 0.83
In vivo and in vitro studies of immunoglobulin gene somatic hypermutation. Philos Trans R Soc Lond B Biol Sci (2001) 0.83
Creation of mice expressing human antibody light chains by introduction of a yeast artificial chromosome containing the core region of the human immunoglobulin kappa locus. Biotechnology (N Y) (1993) 0.81
The Ig kappa 3'-enhancer triggers gene expression in early B lymphocytes but its activity is enhanced on B cell activation. Int Immunol (1996) 0.81
Regulated activity of the IgH intron enhancer (E mu) in the T lymphocyte lineage. Int Immunol (1995) 0.80
Production of antigen-specific human monoclonal antibodies: comparison of mice carrying IgH/kappa or IgH/kappa/lambda transloci. Biotechniques (2002) 0.79
Lymphoid-specific transcriptional activation by components of the IgH enhancer: studies on the E2/E3 and octanucleotide elements. Nucleic Acids Res (1990) 0.77
Construction, function and immunogenicity of recombinant monoclonal antibodies. Behring Inst Mitt (1990) 0.76
Novel antibodies by DNA manipulation. Prog Allergy (1988) 0.76
The expression of immunoglobulin genes. Immunol Today (1988) 0.75
Minicircular ColE1-related DNA in strains of Klebsiella aerogenes selected for fast growth on xylitol. J Gen Microbiol (1980) 0.75
Structure of an experimentally evolved gene duplication encoding ribitol dehydrogenase in a mutant of Klebsiella aerogenes. J Gen Microbiol (1981) 0.75